LS Investment Advisors’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

LS Investment Advisors’s Portfolio SGNT Stock Details SGNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-1,004	Closed	-$15K	–	1883
2016 Q2	$15K	Buy	1,004 +255	+34%	+$3.28K	﹤0.01%	1580
2016 Q1	$9K	Hold	749	–	–	﹤0.01%	1662
2015 Q4	$12K	Hold	749	–	–	﹤0.01%	1616
2015 Q3	$11K	Hold	749	–	–	﹤0.01%	1641
2015 Q2	$18K	Buy	+749	New	+$17.9K	﹤0.01%	1546

LS Investment Advisors's SGNT Position: Q3 2016 in Review

LS Investment Advisors sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q3 2016, closing a stake of 1,004 shares — an estimated $15K sold.

LS Investment Advisors first reported a position in SGNT in Q2 2015 and held it in 5 quarters. The position peaked at $18K in Q2 2015. 0 funds tracked by Wall St. Rank hold SGNT as of Q3 2016.

LS Investment Advisors reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q3 2016 after selling out during the quarter.
LS Investment Advisors sold 1,004 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2016, an estimated $15K.
LS Investment Advisors first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q2 2015 and held it in 5 quarters.
LS Investment Advisors's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $18K in Q2 2015.
0 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2016.

Based on LS Investment Advisors's 13F filing for Q3 2016, filed 8 Nov 2016.